As summarized in Table 3, in line with the results of tumor-infiltrating immune cells, 31 kinds of chemokines, such as CCL2, XCL2, CCR2, CCL5, and CCR5, were found to be overexpressed in patients of the CIMP-L subgroup, while only 7 kinds of chemokines, such as CXCL14 and CXCL16, were found to be increased in patients of the CIMP-M and CIMP-H subgroup. This evidence concerns the gene CCR2 and neoplasm.